Notification report

General information

Notification Number

Member State to which the notification was sent

Date of acknowledgement from the Member State Competent Authority

Title of the Project
Notification on the deliberate release into the environment of transgenic potatoes with modified carbohydrate metabolism 'Solavista-01'

Proposed period of release:
01/01/2003 to 31/12/2012

Name of the Institute(s) or Company(ies)
Solavista GmbH&CoKG, ;

3. Is the same GMPt release planned elsewhere in the Community?

Has the same GMPt been notified elsewhere by the same notifier?

Genetically modified plant

Complete name of the recipient or parental plant(s)
Common NameFamily NameGenusSpeciesSubspeciesCultivar/breeding line
potatosolanaceaesolanumsolanum tuberosumtuberosumAveka, Festien

2. Description of the traits and characteristics which have been introduced or modified, including marker genes and previous modifications:
-genes involved in carbohydrate metabolism
-gene confering resistance to L-phosphinothricine

Genetic modification

3. Type of genetic modification:

In case of insertion of genetic material, give the source and intended function of each constituent fragment of the region to be inserted:
Left and right border: source A. tumefaciens, required for T-DNA transfer; 35S promotor: source CaMV, constitutive expression of the marker gene; ocs- and nos terminator: source A. tumefaciens, termination of transcription; genes involved in carbohydrate metabolism: source potato, modification of carbohydrate metabolism; B33 patatin promotor: source potato, expression of genes involved in carbohydrate metabolism

6. Brief description of the method used for the genetic modification:
A. tumefaciens mediated gene transfer

Experimental Release

1. Purpose of the release:
-sample production for physical, chemical, biochemical and other analyses
-agronomic performance of the GMP
-gain new data on the environmental and health impact of the released GMP

2. Geographical location of the site:
Tarnow, Mecklenburg-Vorpommern

3. Size of the site (m2):
maximal annual trial size in Tarnow: 50.000 m2

Environmental Impact and Risk Management

Summary of the potential environmental impact from the release of the GMPts:
The genetically modified plants differ in their starch composition. In addition, they contain a gene confering resistance to L-phosphinothricine. A selective advantage of the GMP can only be observed when a selective herbicide containing L-phosphinothricine as active ingredient is applied. The altered starch qualities do not lead to any selective advantages. No differences in hybridisation potential with wild species, persistence and invasiveness of the GMP, or susceptibility of the GMP to plant pathogens compared to the unmodified predecessor plant are expected. No difference in toxicity and allergenicity of the GMP are expected, because the introduced genes do not possess such potential. No negative effects on non-target organisms resulting from the genetic modification are expected.

Brief description of any measures taken for the management of risks:
Pollen dispersal from the GMP to non-transgenic potatoes is prevented by an isolation distance of at least 10 m. There are only two wild potato species in Europe, Solanum dulcamara and Solanum nigrum. Both wild species do not hybridize successfully with Solanum tuberosum.

Summary of foreseen field trial studies focused to gain new data on environmental and human health impact from the release:
Field release of the GMP is done to produce enough sample material for physical, chemical, biochemical and other analyses and to study the agronomic performance of the genetically modified plant. Studies analysing the environmental and health impact of the GMPTs may also be realized.

Final report

European Commission administrative information

Consent given by the Member State Competent Authority:
17/02/2003 00:00:00